Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Biomarker cruises in sepsis: who is the CAPTAIN? Discussion on "Circulating biomarkers may be unable to detect infection at the early phase of sepsis in ICU patients: the CAPTAIN prospective multicenter cohort study".

Briassoulis G, Briassoulis P, Miliaraki M, Ilia S, Parlato M, Philippart F, Rouquette A, Moucadel V, Cavaillon JM, Misset B; Combined Approach for The eArly diagnosis of INfection in sepsis (CAPTAIN) study group.

Intensive Care Med. 2019 Jan;45(1):132-133. doi: 10.1007/s00134-018-5451-y. Epub 2019 Jan 7. No abstract available.

PMID:
30617463
2.

Efficacy of Ruxolitinib Therapy in a Patient With Severe Enterocolitis Associated With a STAT3 Gain-of-Function Mutation.

Parlato M, Charbit-Henrion F, Abi Nader E, Begue B, Guegan N, Bruneau J, Khater S, Macintyre E, Picard C, Frédéric RL, Le Bourhis L, Allez M, Goulet O, Cellier C, Hermine O, Cerf-Bensussan N, Malamut G.

Gastroenterology. 2019 Mar;156(4):1206-1210.e1. doi: 10.1053/j.gastro.2018.11.065. Epub 2018 Dec 15. No abstract available. Erratum in: Gastroenterology. 2019 Jun;156(8):2356.

3.

Circulating biomarkers may be unable to detect infection at the early phase of sepsis in ICU patients: the CAPTAIN prospective multicenter cohort study.

Parlato M, Philippart F, Rouquette A, Moucadel V, Puchois V, Blein S, Bedos JP, Diehl JL, Hamzaoui O, Annane D, Journois D, Ben Boutieb M, Estève L, Fitting C, Treluyer JM, Pachot A, Adib-Conquy M, Cavaillon JM, Misset B; Captain Study Group.

Intensive Care Med. 2018 Jul;44(7):1061-1070. doi: 10.1007/s00134-018-5228-3. Epub 2018 Jun 30.

PMID:
29959455
4.

Diagnostic Yield of Next-Generation Sequencing in Very Early-Onset Inflammatory Bowel Diseases: A Multicenter Study.

Charbit-Henrion F, Parlato M, Hanein S, Duclaux-Loras R, Nowak J, Begue B, Rakotobe S, Bruneau J, Fourrage C, Alibeu O, Rieux-Laucat F, Lévy E, Stolzenberg MC, Mazerolles F, Latour S, Lenoir C, Fischer A, Picard C, Aloi M, Amil Dias J, Ben Hariz M, Bourrier A, Breuer C, Breton A, Bronski J, Buderus S, Cananzi M, Coopman S, Crémilleux C, Dabadie A, Dumant-Forest C, Egritas Gurkan O, Fabre A, Fischer A, German Diaz M, Gonzalez-Lama Y, Goulet O, Guariso G, Gurcan N, Homan M, Hugot JP, Jeziorski E, Karanika E, Lachaux A, Lewindon P, Lima R, Magro F, Major J, Malamut G, Mas E, Mattyus I, Mearin LM, Melek J, Navas-Lopez VM, Paerregaard A, Pelatan C, Pigneur B, Pinto Pais I, Rebeuh J, Romano C, Siala N, Strisciuglio C, Tempia-Caliera M, Tounian P, Turner D, Urbonas V, Willot S, Ruemmele FM, Cerf-Bensussan N.

J Crohns Colitis. 2018 May 18. doi: 10.1093/ecco-jcc/jjy068. [Epub ahead of print]

5.

Human ALPI deficiency causes inflammatory bowel disease and highlights a key mechanism of gut homeostasis.

Parlato M, Charbit-Henrion F, Pan J, Romano C, Duclaux-Loras R, Le Du MH, Warner N, Francalanci P, Bruneau J, Bras M, Zarhrate M, Bègue B, Guegan N, Rakotobe S, Kapel N, De Angelis P, Griffiths AM, Fiedler K, Crowley E, Ruemmele F, Muise AM, Cerf-Bensussan N.

EMBO Mol Med. 2018 Apr;10(4). pii: e8483. doi: 10.15252/emmm.201708483.

6.

First Identification of Biallelic Inherited DUOX2 Inactivating Mutations as a Cause of Very Early Onset Inflammatory Bowel Disease.

Parlato M, Charbit-Henrion F, Hayes P, Tiberti A, Aloi M, Cucchiara S, Bègue B, Bras M, Pouliet A, Rakotobe S, Ruemmele F, Knaus UG, Cerf-Bensussan N.

Gastroenterology. 2017 Aug;153(2):609-611.e3. doi: 10.1053/j.gastro.2016.12.053. Epub 2017 Jul 3. No abstract available.

PMID:
28683258
7.

Specific recruitment of circulating angiogenic cells using biomaterials as filters.

Parlato M, Molenda J, Murphy WL.

Acta Biomater. 2017 Jul 1;56:65-79. doi: 10.1016/j.actbio.2017.03.048. Epub 2017 Apr 1.

8.

Deficiency in Mucosa-associated Lymphoid Tissue Lymphoma Translocation 1: A Novel Cause of IPEX-Like Syndrome.

Charbit-Henrion F, Jeverica AK, Bègue B, Markelj G, Parlato M, Avčin SL, Callebaut I, Bras M, Parisot M, Jazbec J, Homan M, Ihan A, Rieux-Laucat F, Stolzenberg MC, Ruemmele FM, Avčin T, Cerf-Bensussan N; GENIUS Group.

J Pediatr Gastroenterol Nutr. 2017 Mar;64(3):378-384. doi: 10.1097/MPG.0000000000001262.

PMID:
27253662
9.

Reducing hypoxia and inflammation during invasive pulmonary aspergillosis by targeting the Interleukin-1 receptor.

Gresnigt MS, Rekiki A, Rasid O, Savers A, Jouvion G, Dannaoui E, Parlato M, Fitting C, Brock M, Cavaillon JM, van de Veerdonk FL, Ibrahim-Granet O.

Sci Rep. 2016 May 24;6:26490. doi: 10.1038/srep26490.

10.

Infection-Mediated Priming of Phagocytes Protects against Lethal Secondary Aspergillus fumigatus Challenge.

Savers A, Rasid O, Parlato M, Brock M, Jouvion G, Ryffel B, Cavaillon JM, Eberl G, Ibrahim-Granet O.

PLoS One. 2016 Apr 14;11(4):e0153829. doi: 10.1371/journal.pone.0153829. eCollection 2016.

11.

Biomaterial arrays with defined adhesion ligand densities and matrix stiffness identify distinct phenotypes for tumorigenic and nontumorigenic human mesenchymal cell types.

Hansen TD, Koepsel JT, Le NN, Nguyen EH, Zorn S, Parlato M, Loveland SG, Schwartz MP, Murphy WL.

Biomater Sci. 2014 May;2(5):745-756. doi: 10.1039/C3BM60278H. Epub 2014 Jan 22.

12.

Host response biomarkers in the diagnosis of sepsis: a general overview.

Parlato M, Cavaillon JM.

Methods Mol Biol. 2015;1237:149-211. doi: 10.1007/978-1-4939-1776-1_15. Review.

PMID:
25319788
13.

Bacterial translocation and plasma cytokines during transcatheter and open-heart aortic valve implantation.

Adrie C, Parlato M, Salmi L, Adib-Conquy M, Bical O, Deleuze P, Fitting C, Cavaillon JM, Monchi M.

Shock. 2015 Jan;43(1):62-7. doi: 10.1097/SHK.0000000000000262.

PMID:
25202829
14.

Substratum-induced differentiation of human pluripotent stem cells reveals the coactivator YAP is a potent regulator of neuronal specification.

Musah S, Wrighton PJ, Zaltsman Y, Zhong X, Zorn S, Parlato MB, Hsiao C, Palecek SP, Chang Q, Murphy WL, Kiessling LL.

Proc Natl Acad Sci U S A. 2014 Sep 23;111(38):13805-10. doi: 10.1073/pnas.1415330111. Epub 2014 Sep 8.

15.

Poly(ethylene glycol) hydrogels with adaptable mechanical and degradation properties for use in biomedical applications.

Parlato M, Reichert S, Barney N, Murphy WL.

Macromol Biosci. 2014 May;14(5):687-98. Epub 2014 Jan 25.

16.

NOD-like receptors in intestinal homeostasis and epithelial tissue repair.

Parlato M, Yeretssian G.

Int J Mol Sci. 2014 May 30;15(6):9594-627. doi: 10.3390/ijms15069594. Review.

17.

CD24-triggered caspase-dependent apoptosis via mitochondrial membrane depolarization and reactive oxygen species production of human neutrophils is impaired in sepsis.

Parlato M, Souza-Fonseca-Guimaraes F, Philippart F, Misset B; Captain Study Group, Adib-Conquy M, Cavaillon JM.

J Immunol. 2014 Mar 1;192(5):2449-59. doi: 10.4049/jimmunol.1301055. Epub 2014 Feb 5.

18.

Adaptable poly(ethylene glycol) microspheres capable of mixed-mode degradation.

Parlato M, Johnson A, Hudalla GA, Murphy WL.

Acta Biomater. 2013 Dec;9(12):9270-80. doi: 10.1016/j.actbio.2013.08.011. Epub 2013 Aug 17.

19.

Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging.

Galiger C, Brock M, Jouvion G, Savers A, Parlato M, Ibrahim-Granet O.

Antimicrob Agents Chemother. 2013 Jul;57(7):3046-59. doi: 10.1128/AAC.01660-12. Epub 2013 Apr 15.

20.

Interferon-γ and granulocyte/monocyte colony-stimulating factor production by natural killer cells involves different signaling pathways and the adaptor stimulator of interferon genes (STING).

Souza-Fonseca-Guimaraes F, Parlato M, de Oliveira RB, Golenbock D, Fitzgerald K, Shalova IN, Biswas SK, Cavaillon JM, Adib-Conquy M.

J Biol Chem. 2013 Apr 12;288(15):10715-21. doi: 10.1074/jbc.M112.435602. Epub 2013 Feb 26.

21.

Toll-like receptors expression and interferon-γ production by NK cells in human sepsis.

Souza-Fonseca-Guimaraes F, Parlato M, Philippart F, Misset B, Cavaillon JM, Adib-Conquy M; Captain study group.

Crit Care. 2012 Oct 25;16(5):R206. doi: 10.1186/cc11838.

22.

DNAemia detection by multiplex PCR and biomarkers for infection in systemic inflammatory response syndrome patients.

Fitting C, Parlato M, Adib-Conquy M, Memain N, Philippart F, Misset B, Monchi M, Cavaillon JM, Adrie C.

PLoS One. 2012;7(6):e38916. doi: 10.1371/journal.pone.0038916. Epub 2012 Jun 15.

23.

NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis.

Souza-Fonseca-Guimaraes F, Parlato M, Fitting C, Cavaillon JM, Adib-Conquy M.

J Immunol. 2012 Jun 15;188(12):5850-8. doi: 10.4049/jimmunol.1103616. Epub 2012 May 7.

24.

Exceptionally stable fluorous emulsions for the intravenous delivery of volatile general anesthetics.

Jee JP, Parlato MC, Perkins MG, Mecozzi S, Pearce RA.

Anesthesiology. 2012 Mar;116(3):580-5. doi: 10.1097/ALN.0b013e3182475d4d.

25.

Synthesis, characterization, and applications of hemifluorinated dibranched amphiphiles.

Parlato MC, Jee JP, Teshite M, Mecozzi S.

J Org Chem. 2011 Aug 19;76(16):6584-91. doi: 10.1021/jo200835y. Epub 2011 Jul 21.

26.

Mechanisms of TNF induction by heat-killed Staphylococcus aureus differ upon the origin of mononuclear phagocytes.

Kapetanovic R, Parlato M, Fitting C, Quesniaux V, Cavaillon JM, Adib-Conquy M.

Am J Physiol Cell Physiol. 2011 Apr;300(4):C850-9. doi: 10.1152/ajpcell.00187.2010. Epub 2011 Jan 5.

27.

Bacteriophage-resistant Staphylococcus aureus mutant confers broad immunity against staphylococcal infection in mice.

Capparelli R, Nocerino N, Lanzetta R, Silipo A, Amoresano A, Giangrande C, Becker K, Blaiotta G, Evidente A, Cimmino A, Iannaccone M, Parlato M, Medaglia C, Roperto S, Roperto F, Ramunno L, Iannelli D.

PLoS One. 2010 Jul 22;5(7):e11720. doi: 10.1371/journal.pone.0011720.

28.

Contribution of NOD2 to lung inflammation during Staphylococcus aureus-induced pneumonia.

Kapetanovic R, Jouvion G, Fitting C, Parlato M, Blanchet C, Huerre M, Cavaillon JM, Adib-Conquy M.

Microbes Infect. 2010 Sep;12(10):759-67. doi: 10.1016/j.micinf.2010.05.003. Epub 2010 May 21.

PMID:
20493961
29.

Bacteriophage therapy of Salmonella enterica: a fresh appraisal of bacteriophage therapy.

Capparelli R, Nocerino N, Iannaccone M, Ercolini D, Parlato M, Chiara M, Iannelli D.

J Infect Dis. 2010 Jan 1;201(1):52-61. doi: 10.1086/648478.

PMID:
19929381
30.

STICS: surface-tethered iterative carbohydrate synthesis.

Pornsuriyasak P, Ranade SC, Li A, Parlato MC, Sims CR, Shulga OV, Stine KJ, Demchenko AV.

Chem Commun (Camb). 2009 Apr 14;(14):1834-6. doi: 10.1039/b817684a. Epub 2009 Feb 18.

PMID:
19319417
31.

Heterogeneous shedding of Brucella abortus in milk and its effect on the control of animal brucellosis.

Capparelli R, Parlato M, Iannaccone M, Roperto S, Marabelli R, Roperto F, Iannelli D.

J Appl Microbiol. 2009 Jun;106(6):2041-7. doi: 10.1111/j.1365-2672.2009.04177.x. Epub 2009 Feb 27.

32.

Anti-inflammatory activity of a new class of nitric oxide synthase inhibitors that release nitric oxide.

Botta M, Distrutti E, Mencarelli A, Parlato MC, Raffi F, Cipriani S, Fiorucci S.

ChemMedChem. 2008 Oct;3(10):1580-8. doi: 10.1002/cmdc.200800201.

PMID:
18720486
33.

Mannose-binding lectin haplotypes influence Brucella abortus infection in the water buffalo (Bubalus bubalis).

Capparelli R, Parlato M, Amoroso MG, Roperto S, Marabelli R, Roperto F, Iannelli D.

Immunogenetics. 2008 Apr;60(3-4):157-65. doi: 10.1007/s00251-008-0284-4. Epub 2008 Mar 11.

PMID:
18330558
34.

Application of glycosyl thioimidates in solid-phase oligosaccharide synthesis.

Parlato MC, Kamat MN, Wang H, Stine KJ, Demchenko AV.

J Org Chem. 2008 Mar 7;73(5):1716-25. doi: 10.1021/jo701902f. Epub 2008 Feb 1.

PMID:
18237185
35.

Experimental phage therapy against Staphylococcus aureus in mice.

Capparelli R, Parlato M, Borriello G, Salvatore P, Iannelli D.

Antimicrob Agents Chemother. 2007 Aug;51(8):2765-73. Epub 2007 May 21.

36.

DNA and LNA oligonucleotides containing N2'-functionalised derivatives of 2'-amino-2'-deoxyuridine.

Kalra N, Parlato MC, Parmar VS, Wengel J.

Bioorg Med Chem Lett. 2006 Jun 15;16(12):3166-9. Epub 2006 Apr 18.

PMID:
16621554
37.

Small surface-associated factors mediate adhesion of a food-isolated strain of Lactobacillus fermentum to Caco-2 cells.

Baccigalupi L, Di Donato A, Parlato M, Luongo D, Carbone V, Rossi M, Ricca E, De Felice M.

Res Microbiol. 2005 Aug;156(7):830-6.

PMID:
16125909
38.

S-adenosyl-L-methionine N-ole-1-oyltaurate: pharmacokinetic of the orally administered salt in rats.

Morana A, De Rosa A, Cartenì M, Parlato M, De Rosa M.

Int J Pharm. 2001 Nov 6;230(1-2):47-55.

PMID:
11672955
39.

Nutrition advocacy and national development: the PROFILES programme and its application.

Burkhalter BR, Abel E, Aguayo V, Diene SM, Parlato MB, Ross JS.

Bull World Health Organ. 1999;77(5):407-15.

40.

Promotion of breast-feeding in the media.

Parlato MB.

World Health Forum. 1992;13(2-3):197. No abstract available.

PMID:
1418337
41.

Reproductive performance in women with complete septate uteri.

Maneschi F, Parlato M, Incandela S, Maneschi M.

J Reprod Med. 1991 Oct;36(10):741-4.

PMID:
1956015
42.

[Emergency situations in dental offices. 5. Medico-legal aspects and insurance].

Parlato M, Ambrosio R, Tortora A.

Arch Stomatol (Napoli). 1990 Oct-Dec;31(4):859-71. Italian. No abstract available.

PMID:
2100495
43.

[Emergency situations in the dental office. 4. Prevention and organization].

Parlato M, Del Duca P.

Arch Stomatol (Napoli). 1990 Oct-Dec;31(4):767-73. Italian. No abstract available.

PMID:
2100487
44.

[Emergency situations in the dental office. 3. Pharmacology].

Parlato M, Mangino C, Del Core G.

Arch Stomatol (Napoli). 1990 Oct-Dec;31(4):707-14. Italian. No abstract available.

PMID:
2100482
45.

[Emergency situations in ambulatory dentistry. 2. Execution technique of therapeutic measures].

Parlato M, Alessandrella G, Ferraro R.

Arch Stomatol (Napoli). 1990 Jul-Sep;31(3):565-71. Italian. No abstract available.

PMID:
2097971
46.

The use of mass media to promote breastfeeding.

Parlato MB.

Int J Gynaecol Obstet. 1990;31 Suppl 1:105-110. doi: 10.1016/0020-7292(90)90086-Z.

PMID:
29645105
47.

[Eating habits and oral hygiene level in a group of deaf children].

Parlato M, Ferraro R.

Arch Stomatol (Napoli). 1990 Jan-Mar;31(1):63-5. Italian. No abstract available.

PMID:
2291711
48.

[Removal of carious tissue with non-conventional methods: Caridex-therapy].

Parlato M, del Duca P.

Arch Stomatol (Napoli). 1990 Jan-Mar;31(1):33-7. Review. Italian.

PMID:
2291708
49.

[Drug induced pigmentation changes in the palate].

Parlato M, Del Core G.

Arch Stomatol (Napoli). 1990 Jan-Mar;31(1):139-45. Review. Italian. No abstract available.

PMID:
2291702
50.

[Chlorhexidine: review of the literature and comparison with Oradyne Z].

Parlato M, Ambrosio R, Del Duca P.

Arch Stomatol (Napoli). 1990 Jan-Mar;31(1):129-37. Review. Italian.

PMID:
2291701

Supplemental Content

Loading ...
Support Center